SCHEMBL2898110

SCHEMBL2898110

Fc1cc(Br)ccc1-c1nc2ccccc2[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.67
RAB9A P51151 8/20 0.67
ALDH1A1 P00352 6/20 0.67
PKM P14618 2/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
PDPK1 O15530 1/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
KDM4E B2RXH2 5/20 0.53
NPSR1 Q6W5P4 3/20 0.53
HSD17B10 Q99714 3/20 0.53
ABCB11 O95342 1/20 0.53
TP53 P04637 1/20 0.53
AMY1A P0DUB6 4/20 0.51
PTGES O14684 1/20 0.51
HPGD P15428 4/20 0.50
GAA P10253 2/20 0.50
ESR1 P03372 1/20 0.50
GPR55 Q9Y2T6 1/20 0.50
GLA P06280 1/20 0.50
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3512712 0.88 NPC1 (0.67) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL9725328 0.86 PDPK1 (0.61) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL31429607 0.83 AMY1A (0.62) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL9888370 0.83 NPC1 (0.69) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL26597176 0.82 ALDH1A1 (0.67) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL6263629 0.82 NPC1 (0.67) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL15396523 0.82 ALDH1A1 (0.67) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL16050067 0.81 AMY1A (0.57) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL31027904 0.80 NPC1 (1.00) NPC1RAB9AALDH1A1PKML3MBTL1
SCHEMBL2243125 0.80 NPC1 (1.00) NPC1RAB9AALDH1A1PKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2010-11-11 US disclosed
EP-1799677-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS Ranbaxy Laboratories Limited (IN) 2007-06-27 EP disclosed
WO-2006038100-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS OXA1L, PDK4, MLYCD NPC1 3916/4885RAB9A 4328/4885ALDH1A1 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.